✅ France: oncology diagnostics in Marseille
✅ Sweden: biomanufacturing centre in Södertälje
✅ Switzerland: Roche opens R&D centre
✅ UK: Debenhams gets a makoever
To maximise the value of their enormous real estate portfolios, pharma companies have two key strategies: continuous portfolio optimisation and capital unlocking through sale and leaseback (S&LB) transactions.